scispace - formally typeset
N

Nosratollah Zarghami

Researcher at Tabriz University of Medical Sciences

Publications -  349
Citations -  12087

Nosratollah Zarghami is an academic researcher from Tabriz University of Medical Sciences. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 43, co-authored 311 publications receiving 8584 citations. Previous affiliations of Nosratollah Zarghami include Mount Sinai Hospital, Toronto & University of Toronto.

Papers
More filters
Journal ArticleDOI

Liposome: classification, preparation, and applications

TL;DR: This paper summarizes exclusively scalable techniques and focuses on strengths and limitations in respect to industrial applicability and regulatory requirements concerning liposomal drug formulations based on FDA and EMEA documents.
Journal ArticleDOI

Carbon nanotubes: properties, synthesis, purification, and medical applications

TL;DR: The strength and flexibility of carbon nanotubes make them of potential use in controlling other nanoscale structures, which suggests they will have a significant role in nanotechnology engineering.
Journal ArticleDOI

PLGA-based nanoparticles as cancer drug delivery systems.

TL;DR: In this article, the structure and properties of poly (lactic-co-glycolic acid) copolymers synthesized by ring-opening polymerization of DL-lactide and glicolide were characterized using 1H nuclear magnetic resonance spectroscopy, gel permeation chromatography, Fourier transform infrared spectrograph and differential scanning calorimetry.

PLGA-based nanoparticles as cancer drug delivery systems

TL;DR: Methods of preparation and characterization, various surface modifications, encapsulation of diverse anticancer drugs, active or passive tumor targeting and different release mechanisms of PLGA nanoparticles are discussed.
Journal ArticleDOI

Preparation and in vitro evaluation of doxorubicin-loaded Fe3O4 magnetic nanoparticles modified with biocompatible copolymers

TL;DR: In this study, superparamagnetic iron oxide nanoparticles and the anticancer drug, doxorubicin hydrochloride, were encapsulated into poly (D, L-lactic-co-glycolic acid) poly (ethylene glycol) (PLGA-PEG) nanoparticles for local treatment and showed potential for use in biomedical application.